
Measurable patient characteristics that predict better tolerance have not been widely studied and are desperately needed in clinical practice to inform treatment decision-making and individualize care for each older adult with AML.

Your AI-Trained Oncology Knowledge Connection!


Published: July 31st 2013 | Updated: